Fig. 1From: Anorexia, pain and peripheral neuropathy are associated with a decrease in quality of life in patients with advanced pancreatic cancer receiving outpatient chemotherapy — a retrospective observational studyComparison of the incidence of grade ≥ 2 AEs affecting QOL (i.e., nausea, peripheral neuropathy, pain) (A) and the average of EQ-5D-5 L utility value (B), before and after pharmaceutical intervention (B: Wilcoxon signed-rank test)Back to article page